SIGMAR1 and glioblastoma: Eventually, the results of the fundamental characterisation of the components of the experimental setting, i.e., the mouse model and the PET radioligand, with respect to availability of and selectivity to sig1R, prompted us to proceed with dynamic PET studies in the orthotopic U87-MG glioblastoma mouse model.